| Abasaglar (previously Abasria) |
insulin glargine | 甘精胰岛素 | A10AE04 | 2014-09-09 | Eli Lilly Regional Operations GmbH | Authorised |
| Abilify |
aripiprazole | 阿立哌唑 | N05AX12 | 2004-06-04 | Otsuka Pharmaceutical Europe Ltd | Authorised |
| Abilify Maintena |
aripiprazole | 阿立哌唑 | N05AX12 | 2013-11-15 | Otsuka Pharmaceutical Europe Ltd | Authorised |
| Ablavar (previously Vasovist) |
gadofosveset trisodium | 钆磷维塞三钠 | V08CA | 2005-10-03 | TMC Pharma Services Ltd.
| Withdrawn |
| Abraxane |
paclitaxel | 紫杉醇 | L01CD01 | 2008-01-11 | Celgene Europe Ltd
? | Authorised |
| Abseamed |
epoetin alfa | 促红素α | B03XA01 | 2007-08-28 | Medice Arzneimittel Pütter GmbH & Co. KG | Authorised |
| Accofil |
filgrastim | 非格司亭 | L03AA02 | 2014-09-18 | Accord Healthcare Ltd | Authorised |
| Aclasta |
zoledronic acid | 唑来膦酸 | M05BA08 | 2005-04-15 | Novartis Europharm Limited | Authorised |
| Acomplia |
rimonabant | 利莫纳班 | A08AX01 | 2006-06-19 | sanofi-aventis | Withdrawn |
| Acrescent |
memantine hydrochloride / donepezil hydrochloride | 盐酸美金刚胺；盐酸多奈哌齐 | N06D | --- | H. Lundbeck A/S | Refused |
| Actelsar HCT |
telmisartan / hydrochlorothiazide | 替米沙坦；氢氯噻嗪 | C09DA07 | 2013-03-13 | Actavis Group hf | Authorised |
| Actos |
pioglitazone | 吡格列酮 | A10BG03 | 2000-10-13 | Takeda Pharma A/S | Authorised |
| Actraphane |
insulin human (rDNA) | 人胰岛素(rDNA) | A10AD01 | 2002-10-07 | Novo Nordisk A/S | Authorised |
| Actrapid |
human insulin(rDNA) | 人胰岛素(rDNA) | A10AB01 | 2002-10-07 | Novo Nordisk A/S | Authorised |
| Adasuve |
loxapine | 洛沙平 | N05AH01 | 2013-02-20 | Ferrer Internacional s.a. | Authorised |
| Adcetris |
brentuximab vedotin | 维汀-布仑妥昔单抗 | L01XC12 | 2012-10-25 | Takeda Pharma A/S | Authorised |
| Adcirca (previously Tadalafil Lilly) |
tadalafil | 他达拉非 | G04BE08 | 2008-10-01 | Eli Lilly Nederland B.V. | Authorised |
| Adempas |
riociguat | 利奥西呱 | C02KX05 | 2014-03-27 | Bayer AG | Authorised |
| Adenuric |
febuxostat | 非布司他 | M04AA03 | 2008-04-21 | Menarini International Operations Luxembourg S.A. (MIOL) | Authorised |
| Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) |
pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) | 大流行流感疫苗H5N1 | J07BB02 | 2009-10-10 | GlaxoSmithKline Biologicals S.A.
| Authorised |
